Balloon aortic valvotomy (BAV) is an alternative to surgical valvotomy in infants and children. We compared BAV in 16 consecutive neonates (1985)(1986)(1987)(1988) to surgical valvotomy in a prior group of 16 consecutive neonates (1978)(1979)(1980)(1981)(1982)(1983)(1984) 
strated that the severity of congenital valvar aortic stenosis can be reduced with minimal mortality and acceptable morbidity.17-221f the efficacy, morbidity, and mortality of balloon dilation in neonates with critical valvar aortic stenosis are no worse than the results of surgical valvotomy, it might be the initial form of management. We, therefore, compared surgical valvotomy in 16 consecutive neonates (1978) (1979) (1980) (1981) (1982) (1983) (1984) ( tive heart failure or shock at presentation, and five received prostaglandin El to maintain patency of the ductus arteriosus (Table 1) .
Associated lesions were present in 14 patients, including patent ductus arteriosus in seven, coarctation of the aorta in one, and mitral regurgitation in 11 (moderate or severe in seven and mild in four). For both surgical and balloon dilation groups, early death was defined as death occurring within 30 days of the initial procedure. Patients undergoing stage I palliation for hypoplastic left heart syndrome were considered failures and excluded from further follow-up.
Balloon Dilation Technique
Informed consent was obtained from the parents in accordance with the guidelines of the Committee on Clinical Investigation. The methodology outlined below is our current approach and has been modified in response to our initial experience.
All patients are premedicated with morphine sulfate (0.1 mg/kg body wt) and receive local anesthesia with 1% xylocaine for percutaneous cannulation of the femoral vessels. In neonates less than 72 hours old, we attempt to use the umbilical artery. If the aortic valve cannot be crossed within 30 minutes by umbilical artery access, the femoral artery is used. The femoral artery was used in 10 For dilation, the aortic valve is initially crossed with a soft 0.015-0.021 in. guidewire; over this wire, the cut-off Pigtail catheter is positioned in the left ventricle. The small wire is exchanged for a 0.021-0.028 in. guidewire with a preformed curve that is curled in the apex of the left ventricle. The Pigtail catheter is then exchanged for a balloon dilation catheter (Cook Ine or Mansfield Scientific), which is positioned across the aortic valve and inflated by hand to 3-8 atm or until the waist in the balloon produced by the valve disappears. The actual diameter of the inflated balloon will vary with inflation pressure; small (less than 1 mm) increases in balloon diameter can be achieved by increasing pressure rather than changing to a larger balloon. As a waist is commonly absent in neonates with aortic stenosis (Figure 2 ), two to four inflations are performed to ensure that the balloon is properly positioned. After each inflation, the balloon is deflated rapidly and withdrawn to the descending aorta. Inflation-deflation cycles lasted, at most, 15 seconds. After balloon dilation, left ventricular and ascending aorta pressures are measured. Finally, an aortogram is performed to evaluate the severity of aortic regurgitation after the dilation. The neonates were observed, at least overnight, in the cardiovascular intensive care unit.
Data Analysis
Measured and calculated data are expressed as mean +1 SD. Comparison of the two groups was performed using the unpaired Student's t test. Ap value of less than 0.05 was considered significant.
Results
No significant differences were found between the clinical, hemodynamic, and anatomic characteristics of the surgical and balloon valvotomy groups (Table 1) .
Surgical Group
In the first 30 days after the initial surgical valvotomy, there were six early deaths (Table 2) . Of these, three occurred within 5 days of surgery and were secondary to low cardiac output, and two occurred in patients with small or hypoplastic left ventricles (33% and 61% of predicted normal). At autopsy, the third patient had severe residual aortic stenosis with extensive endocardial fibroelastosis. The other three early deaths occurred during or after repeat operation prompted by severe residual aortic stenosis (PSEG of 60, 84, and 90 mm Hg) and left ventricular dysfunction. In addition to these six deaths, one patient underwent stage I palliation for hypoplastic left heart syndrome and was, therefore, excluded from further follow-up.
Thus, nine patients were available for follow-up.
For this group, the length of the hospitalization ranged from 10 to 20 days (mean, 13 Figure  3 ). He died 3 hours later from low cardiac output.
There were two late deaths, 6-16 weeks after the procedure. Both patients had small left ventricles (71% and 63% of predicted normal) and died secondary to low cardiac output after late repair of coarctation of the aorta.
Thus, excluding the five early failures and two late deaths, there were nine patients available for long-term follow-up. Of these, five were recatheterized 2 weeks to 13.5 months (mean, 5.8 +5.4 months) after the initial balloon dilation. The PSEG ranged from 35 to 60 mm Hg (mean, 45.6+11 mm Hg) and the LVEDP from 7 to 23 mm Hg (mean, 15 .8+6.1 mm Hg). Of these five, two who had symptoms of congestive heart failure and were dependent on mechanical ventilation underwent successful repeat balloon dilation and were subsequently discharged home. None of these five patients had aortic regurgitation and one had moderate mitral regurgitation. The other four survivors had Doppler twodimensional echocardiography studies 3 weeks to 24 months (mean, 9.9±10.6 months) after dilation that showed a residual maximal instantaneous gradient ranging from 20 to 70 mm Hg (mean, 43.8+22.9 mm Hg). All had good left ventricular function and 3 had mild aortic regurgitation. The overall mean follow-up period for the balloon dilation group was 7.6±7.8 months, which is significantly shorter than the 26±17 months follow-up for the surgical group (p< 0.02). The overall residual peak systolic ejection gradient was 44.8+ 16.1 mm Hg, which is not significantly different from the surgical group. In summary, of the 16 patients undergoing balloon dilation, six required a second procedure: two balloon dilations, one surgical valvotomy, and three stage I palliations for hypoplastic left heart syndrome. Excluding the five deaths and two additional patients who underwent stage I palliation for hypoplastic left heart syndrome, nine patients survive.
Discussion
Operative therapy for critical valvar aortic stenosis in neonates has a significant mortality, regardless of the surgical approach. 13'5-12 This mortality has been attributed to the poor preoperative condition of the neonates, associated anomalies, and, in particular, left ventricular hypoplasia and dysfunction.5,7,l91,15
Previous reports of balloon aortic valvotomy in small series of neonates 9,20,24 28 have not compared the results directly with surgical results and have not described the technique in detail. In the largest reported series of neonates, there were five deaths among seven neonates. 20 Our results suggest that in similar groups of neonates with critical valvar aortic stenosis, the efficacy and mortality of surgical and balloon valvotomy may be similar.
There are clearly limitations to our study, which retrospectively compares nonrandomized groups, including the fact that the patients are from different time periods and, therefore, preintervention and postintervention care may differ. It should also be emphasized that the balloon valvotomy group represents the first 16 neonates undergoing balloon dilation at our institution. Of the deaths in the balloon dilation group, three were due in part to technical errors (dilation through a cusp, use of an oversized balloon, and procedure-induced sepsis). It is likely that the incidence of these complications can be reduced with increased experience. Similarly, the surgical results are from an era when myocardial protection may have been suboptimal; current surgical results may have a lower incidence of residual aortic stenosis, especially if cardiopulmonary bypass is used.
The mortality in neonates with small hypoplastic left ventricles was high in both the surgical and balloon dilation groups (three of three and three of six, respectively). Of the three survivors in this group of nine patients, two underwent stage I palliation for hypoplastic left heart syndrome. A small hypoplastic left ventricle has previously been reported to be a high risk factor in this group of patients,79311 but caution is required in assessing operability from left ventricular volumes alone; in the balloon dilation groups, there was a survivor with a left ventricular volume of 41%. Obviously, survival after valvotomy is multifactorial; analysis of anatomic variables other than left ventricular volume and physiologic variables other than gradient may be needed to improve patient selection. Nonetheless, among the neonates with normalsized left ventricles, there were only two of nine deaths (one of these two was found to have a hypoplastic left ventricle on follow-up and underwent stage I palliation) in the balloon dilation group compared with three of 10 in the surgical group.
Technique
Based on the above experience, in neonates less than 72 hours old, we initially attempted passage of a 4-5 mm, low-profile balloon dilation catheter. The aortic valves are soft and can be easily perforated. Thus, accurate assessment of the location of the valve orifice with two-dimensional echocardiography or angiography and the use of very soft wires to cross the valves are important. In almost all cases, the open commissure is between the left and noncoronary cusps,29 and valve perforation should be suspected whenever the wire crosses the valve anteriorly. In neonates, we initially use balloons that are at most 85-90% the anulus diameter, modifying inflation pressure to adjust the actual balloon diameter and allow improved gradient reduction. A BAR of more than 100% may adversely affect outcome and has been associated with increased aortic regurgitation. 18, 21, 24, 26, 27 Assessing the immediate results of balloon dilation in the catheterization laboratory can be difficult. In many neonates, no definite waist is seen. The peak-to-peak systolic ejection gradient in these neonates may not accurately reflect the severity of the obstruction due to impaired myocardial function, left-to-right atrial shunts, and right-to-left ductal shunts. Follow-up in both the surgical and balloon valvotomy groups demonstrated evidence of increasing valve gradients that probably reflects improved left ventricular function after decreasing the gradient across the obstruction. We currently consider the procedure successful when there is significant initial gradient reduction, LVEDP is reduced, no more than mild aortic regurgitation results, and clinical improvement is observed.
Conclusion
Our data suggest that percutaneous balloon valvotomy may be as effective as surgical valvotomy in newborns with critical valvar aortic stenosis. Followup, although brief to date, suggests that relief of stenosis and development of aortic regurgitation after balloon dilation or surgery are comparable.
